Osteoporoseprophylaxe mit Sexualsteroiden: Praxis der Hormonersatztherapie in der Peri- und Postmenopause
Reference13 articles.
1. Breckwoldt M, Keck C, Karck U (1998) Hormonelle Substitutionstherapie und Endometriumkarzinomrisiko. Der Gynäkologe 31:877–884
2. Colditz GA, Egan KM, Stampfer MJ (1993) Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 143:569–573
3. Ginsburg J, Prelevic G, Buller D, Okolo S (1995) Clinical experience with tibolone (Livial) over 8 years. Maturitas 21:71–76
4. Grodstein F, Stampfer MJ, Colditz GA (1997) Postmenopausal hormone therapy and mortality. N Eng J Med 336:1769–1775
5. Henderson BE, Paganini Hill A, Ross RK (1991) Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151:75–78